Investigate Effect on Mean IMT of Probucol And/or CilosTazol in Patients With Coronary Heart dIsease Taking HMGCoA Reductase Inhibitor Therapy (IMPACT on IMT): A Randomized, Multicenter, Multinational Study.
Phase of Trial: Phase IV
Latest Information Update: 28 Apr 2017
At a glance
- Drugs Cilostazol (Primary) ; Probucol (Primary)
- Indications Atherosclerosis; Coronary artery disease; Embolism and thrombosis
- Focus Biomarker; Therapeutic Use
- Acronyms IMPACT-on-IMT
- 10 Jun 2017 Biomarkers information updated
- 25 Apr 2017 Status changed from active, no longer recruiting to completed.
- 19 May 2015 Planned primary completion date changed from 1 Mar 2014 to 1 Dec 2016 as per ClinicalTrials.gov record.